Abbott Surprises Analysts With CE Mark For Freestyle Libre 3
The new continuous glucose sensor is the smallest and thinnest in the world, according to Abbott.
You may also be interested in...
The NHS will now pay for the Libre 3 system as part of its NHS Supply Chain Network.
The market for blood glucose monitoring devices is expected to see double-digit growth, reaching $19.7bn by 2025. This growth is driven largely by the rising demand for smaller, more convenient continuous glucose monitoring (CGMs) devices with improved digital capabilities.
Dexcom’s growth strategy includes growing its core business, expanding into pharmacy sales channel, and expanding into new markets.